Bo Zhan

540 total citations
17 papers, 349 citations indexed

About

Bo Zhan is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bo Zhan has authored 17 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bo Zhan's work include Cancer, Hypoxia, and Metabolism (2 papers), Trace Elements in Health (2 papers) and Epigenetics and DNA Methylation (2 papers). Bo Zhan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Trace Elements in Health (2 papers) and Epigenetics and DNA Methylation (2 papers). Bo Zhan collaborates with scholars based in China, Russia and Japan. Bo Zhan's co-authors include Chuize Kong, Yuanyuan Gao, Tongyi Sun, Chiyuan Piao, Zhe Zhang, Xiankui Liu, Xiaolu Cui, Yuyan Zhu, Jianbin Bi and Da-Xin Gong and has published in prestigious journals such as Journal of Controlled Release, Gene and Oncotarget.

In The Last Decade

Bo Zhan

17 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zhan China 11 210 143 59 36 35 17 349
Huibing Li China 9 295 1.4× 193 1.3× 103 1.7× 35 1.0× 29 0.8× 18 388
Yajun Xie China 10 159 0.8× 54 0.4× 8 0.1× 56 1.6× 35 1.0× 30 348
Xinglong Fan China 9 148 0.7× 77 0.5× 8 0.1× 43 1.2× 44 1.3× 19 273
Jana L. Laidlaw United States 7 226 1.1× 76 0.5× 33 0.6× 17 0.5× 18 0.5× 8 503
Xinxin Zhao China 12 172 0.8× 97 0.7× 12 0.2× 15 0.4× 17 0.5× 21 282
Sebastian Wasserström Sweden 11 232 1.1× 34 0.2× 11 0.2× 20 0.6× 19 0.5× 16 430
Anbarasu Kannan India 12 257 1.2× 107 0.7× 4 0.1× 33 0.9× 31 0.9× 20 385
Cláudia Alessandra Andrade de Paula Brazil 11 221 1.1× 88 0.6× 5 0.1× 39 1.1× 45 1.3× 17 409
Sophia M. Orbach United States 10 70 0.3× 27 0.2× 15 0.3× 62 1.7× 7 0.2× 20 227

Countries citing papers authored by Bo Zhan

Since Specialization
Citations

This map shows the geographic impact of Bo Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhan more than expected).

Fields of papers citing papers by Bo Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhan. The network helps show where Bo Zhan may publish in the future.

Co-authorship network of co-authors of Bo Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zhan. A scholar is included among the top collaborators of Bo Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zhan. Bo Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Zimeng, Bohan Li, Zheng Gong, et al.. (2022). Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma. Frontiers in Cell and Developmental Biology. 10. 977960–977960. 5 indexed citations
2.
Zhan, Bo, et al.. (2021). hZIP1 Inhibits Progression of Clear Cell Renal Cell Carcinoma by Suppressing NF-kB/HIF-1α Pathway. Frontiers in Oncology. 11. 759818–759818. 7 indexed citations
3.
Zhan, Bo, Zhe Zhang, Chiyuan Piao, et al.. (2021). The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer. Journal of Cellular and Molecular Medicine. 25(24). 11244–11256. 12 indexed citations
4.
Sun, Tongyi, Bo Zhan, Weifen Zhang, et al.. (2018). Carboxymethyl chitosan nanoparticles loaded with bioactive peptide OH-CATH30 benefit nonscar wound healing. International Journal of Nanomedicine. Volume 13. 5771–5786. 60 indexed citations
5.
Piao, Chiyuan, Xiaolu Cui, Bo Zhan, et al.. (2018). Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer. Journal of Cellular and Molecular Medicine. 23(3). 2064–2076. 49 indexed citations
6.
Zhan, Bo, Chuize Kong, Zhe Zhang, Xiao Dong, & Naiwen Zhang. (2017). Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis. Experimental and Therapeutic Medicine. 13(5). 2473–2479. 5 indexed citations
7.
Ji, Lü, Bing Zhong, Xi Jiang, et al.. (2017). Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways. Oncotarget. 8(68). 112498–112515. 32 indexed citations
8.
Zhan, Bo, et al.. (2017). Evaluation on the anti-oxidation effects of a thermosensitive chitosan-based hydrogel loaded antioxidin-RL. Journal of Controlled Release. 259. e129–e130. 3 indexed citations
10.
Zhang, Yixiao, Zhe Zhang, Zhenhua Li, et al.. (2016). MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3. Oncology Reports. 36(3). 1293–1300. 28 indexed citations
11.
Cui, Xiaolu, Chuize Kong, Yuyan Zhu, et al.. (2016). miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression. Oncotarget. 7(30). 48547–48561. 37 indexed citations
12.
Sun, Tongyi, Bo Zhan, & Yuanyuan Gao. (2015). A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria. Gene. 571(2). 172–177. 36 indexed citations
13.
Zhang, Zhe, Guojun Zhang, Chuize Kong, et al.. (2015). EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma. Tumor Biology. 36(7). 5071–5079. 18 indexed citations
14.
Yu, Jian, et al.. (2014). Aplasia Ras homolog member I expression induces apoptosis in renal cancer cells via the β-catenin signaling pathway. Molecular Medicine Reports. 11(1). 475–481. 2 indexed citations
15.
Dong, Xiao, Chuize Kong, Zhe Zhang, et al.. (2014). hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Urologic Oncology Seminars and Original Investigations. 32(6). 885–892. 10 indexed citations
16.
Zhan, Bo, et al.. (2013). PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway. Tumor Biology. 34(3). 1759–1766. 12 indexed citations
17.
Zhang, Zhe, et al.. (2012). Variation of Urinary and Serum Trace Elements (Ca, Zn, Cu, Se) in Bladder Carcinoma in China. Asian Pacific Journal of Cancer Prevention. 13(5). 2057–2061. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026